Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 1 6Phase 1/2 4Phase 3 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 52Recruiting 14Active not recruiting 13Terminated 11Unknown 8Not yet recruiting 4Withdrawn 3

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 34Genitourinary 29Breast 25Thoracic 23Lymphoid 22Other hematologic neoplasm 15Gynecologic 14Head & Neck 10CNS 8Sarcoma 5Dermatologic 5Tumor-Agnostic 4Plasma cell 4Myeloid 3Endocrine 3Classical hematology 3Other solid neoplasm 1Other neoplasm 1Other 1NET 1

Conditions

Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Serotonin Syndrome 1Neuroendocrine Tumors 1Head and Neck Neoplasms 1Carcinoid Heart Disease 1

Interventions

telotristat ethyl 1lutetium Lu 177 dotatate 1lanreotide 1fosbretabulin 1combretastatin 1Paclitaxel 1Introns 1Carboplatin 1177Lu-octreotate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Withdrawn × Endocrine × Clear all
NCT04065165 2020-02-05

TELEFIRST

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Endocrine

Carcinoid Heart Disease, Serotonin Syndrome

NCT01860742 2016-04-05

CASTOR

Jules Bordet Institute

Phase 3 Withdrawn
EndocrineNET

Neuroendocrine Tumors

NCT01701349 2014-05-01

FACT2

Mateon Therapeutics

Phase 3 Withdrawn
EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡